Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 277

1.

17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes.

Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, Karl M, Striker GE, Xia X, Elliot S.

Kidney Int. 2009 Jun;75(11):1194-201. doi: 10.1038/ki.2009.69. Epub 2009 Mar 11.

PMID:
19279558
[PubMed - indexed for MEDLINE]
2.

Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.

Susztak K, Raff AC, Schiffer M, Böttinger EP.

Diabetes. 2006 Jan;55(1):225-33.

PMID:
16380497
[PubMed - indexed for MEDLINE]
Free Article
3.

Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats.

Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M.

Lab Invest. 2002 Jan;82(1):25-35.

PMID:
11796823
[PubMed - indexed for MEDLINE]
4.

Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.

Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW.

Kidney Int. 2005 Oct;68(4):1554-61.

PMID:
16164632
[PubMed - indexed for MEDLINE]
5.

Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.

Wang Y, Zhou J, Minto AW, Hack BK, Alexander JJ, Haas M, Li YC, Heilig CW, Quigg RJ.

Kidney Int. 2006 Sep;70(5):882-91. Epub 2006 Jul 5.

PMID:
16820793
[PubMed - indexed for MEDLINE]
6.

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.

Wolf G, Chen S, Ziyadeh FN.

Diabetes. 2005 Jun;54(6):1626-34. Review.

PMID:
15919782
[PubMed - indexed for MEDLINE]
Free Article
7.

Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.

Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Göke B, Wolf E, Wanke R.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F819-29. doi: 10.1152/ajprenal.90665.2008. Epub 2009 Feb 11.

PMID:
19211686
[PubMed - indexed for MEDLINE]
Free Article
8.

Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.

Okada T, Wada J, Hida K, Eguchi J, Hashimoto I, Baba M, Yasuhara A, Shikata K, Makino H.

Diabetes. 2006 Jun;55(6):1666-77.

PMID:
16731829
[PubMed - indexed for MEDLINE]
Free Article
9.

Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.

Zhang M, Liu M, Xiong M, Gong J, Tan X.

J Ethnopharmacol. 2012 May 7;141(1):111-8. doi: 10.1016/j.jep.2012.02.007. Epub 2012 Feb 14.

PMID:
22353431
[PubMed - indexed for MEDLINE]
10.

Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.

Zhou G, Cheung AK, Liu X, Huang Y.

Clin Sci (Lond). 2014 May;126(10):707-20. doi: 10.1042/CS20130223.

PMID:
24195695
[PubMed - indexed for MEDLINE]
11.

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Ziyadeh FN, Wolf G.

Curr Diabetes Rev. 2008 Feb;4(1):39-45. Review.

PMID:
18220694
[PubMed - indexed for MEDLINE]
12.

Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.

Baba M, Wada J, Eguchi J, Hashimoto I, Okada T, Yasuhara A, Shikata K, Kanwar YS, Makino H.

J Am Soc Nephrol. 2005 Nov;16(11):3222-34. Epub 2005 Sep 21.

PMID:
16177004
[PubMed - indexed for MEDLINE]
Free Article
13.

Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology.

Gruden G, Perin PC, Camussi G.

Curr Diabetes Rev. 2005 Feb;1(1):27-40. Review.

PMID:
18220580
[PubMed - indexed for MEDLINE]
14.

Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.

Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T, Sawai K, Yoshioka T, Saito Y, Ogawa Y, Kuwabara T, Sugawara A, Nakao K.

Kidney Int. 2008 Feb;73(4):446-55. Epub 2007 Dec 12.

PMID:
18075496
[PubMed - indexed for MEDLINE]
15.

Renal bone morphogenetic protein-7 protects against diabetic nephropathy.

Wang S, de Caestecker M, Kopp J, Mitu G, Lapage J, Hirschberg R.

J Am Soc Nephrol. 2006 Sep;17(9):2504-12. Epub 2006 Aug 9.

PMID:
16899516
[PubMed - indexed for MEDLINE]
Free Article
16.

Testosterone and 17β-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice.

Doublier S, Lupia E, Catanuto P, Periera-Simon S, Xia X, Korach K, Berho M, Elliot SJ, Karl M.

Kidney Int. 2011 Feb;79(4):404-13. doi: 10.1038/ki.2010.398. Epub 2010 Oct 20.

PMID:
20962747
[PubMed - indexed for MEDLINE]
17.

Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.

Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS.

Exp Clin Endocrinol Diabetes. 2007 Oct;115(9):571-6.

PMID:
17943690
[PubMed - indexed for MEDLINE]
18.

The podocyte: a potential therapeutic target in diabetic nephropathy?

Marshall SM.

Curr Pharm Des. 2007;13(26):2713-20. Review.

PMID:
17897015
[PubMed - indexed for MEDLINE]
19.

Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.

Karl M, Potier M, Schulman IH, Rivera A, Werner H, Fornoni A, Elliot SJ.

Endocrinology. 2005 Feb;146(2):889-900. Epub 2004 Nov 18.

PMID:
15550505
[PubMed - indexed for MEDLINE]
20.

BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.

Mitu GM, Wang S, Hirschberg R.

Am J Physiol Renal Physiol. 2007 Nov;293(5):F1641-8. Epub 2007 Sep 5.

PMID:
17804487
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk